NCT03024255View on ClinicalTrials.gov

A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

September 19, 2017

Study Completion Date

September 19, 2017

Conditions
Hyperhidrosis
Interventions
DRUG

BBI-4000 gel, 5%

BBI-4000 gel, 5% applied once to each axilla daily

DRUG

BBI-4000 gel, 10%

BBI-4000 gel, 10% applied once to each axilla daily

DRUG

BBI-4000 gel, 15%

BBI-4000 gel, 15% applied once to each axilla daily

DRUG

Vehicle (Placebo)

Placebo, applied once to each axilla daily

Sponsors
All Listed Sponsors
lead

Botanix Pharmaceuticals

INDUSTRY